# Recurrent Stroke Prevention Clinical Outcome Study

Study · id `cardio:ct-nct01198496` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01198496](<https://clinicaltrials.gov/study/NCT01198496>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01198496

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: High blood pressure; Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 5000 participants.

## Technical summary

Registry record NCT01198496. Randomized; no masking; primary purpose prevention. Start 2010-10 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 5000 participants (planned count; ClinicalTrials.gov record NCT01198496, source copy `cardio:ctgov-nct01198496-2012-07-31`, retrieved 2026-10-26)
- Start date: 2010-10 (registry gives no type) (ClinicalTrials.gov record NCT01198496, source copy `cardio:ctgov-nct01198496-2012-07-31`, retrieved 2026-10-26)
- Primary completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT01198496, source copy `cardio:ctgov-nct01198496-2012-07-31`, retrieved 2026-10-26)
- Completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT01198496, source copy `cardio:ctgov-nct01198496-2012-07-31`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01198496, source copy `cardio:ctgov-nct01198496-2012-07-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01198496-2012-07-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Recurrent Stroke Prevention Clinical Outcome Study
- Acronym: RESPECTS
- Condition: Hypertension
- Condition: Stroke
- Condition: Blood Pressure
- Intervention (Drug): Losartan, Losartan and HCTZ, Amlodipine , Spironolactone
- Lead sponsor: Biomedis International Ltd.
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: c2e60a8fc31a89f69e731e8fd9fd7770b86ca6989b94c2537dafaaff8fda1610
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
